thyssenkrupp nucera AG & Co. KGaA/€NCH2
1D1W1MYTD1Y5YMAX
Capital at risk
About thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA specializes in the development, engineering, procurement, commissioning, and licensing of high-performance electrolysis technologies, focusing on green hydrogen, chlor-alkali, and hydrochloric acid solutions. Serving industries such as chemical manufacturing, steel production, and refineries, the company has completed over 600 electrolysis projects worldwide, totaling more than 10 gigawatts of installed capacity. Founded in 1960 and headquartered in Dortmund, Germany, thyssenkrupp nucera operates globally with locations in the United States, Italy, Saudi Arabia, Australia, China, and Japan. The company's strategic positioning is bolstered by its extensive experience in electrochemical plant construction and its commitment to advancing green hydrogen production technologies.
- Ticker
- €NCH2
- Sector
- Industrials
- Primary listing
- XETRA
- Employees
- 1,076
- Headquarters
- Dortmund, Germany
- Website
- thyssenkrupp-nucera.com
NCH2 Metrics
BasicAdvanced
€1.1B
-
-€0.50
1.13
-
Price and volume
Market cap
€1.1B
Beta
1.13
52-week high
€11.64
52-week low
€6.92
Average daily volume
62K
Financial strength
Current ratio
2.412
Quick ratio
1.917
Long term debt to equity
0.033
Total debt to equity
0.041
Profitability
EBITDA (TTM)
-61.8
Gross margin (TTM)
9.55%
Net profit margin (TTM)
-11.82%
Operating margin (TTM)
-13.15%
Effective tax rate (TTM)
-8.38%
Revenue per employee (TTM)
€500,000
Management effectiveness
Return on assets (TTM)
-3.72%
Return on equity (TTM)
-8.78%
Valuation
Price to revenue (TTM)
1.96
Price to book
1.53
Price to tangible book (TTM)
1.76
Price to free cash flow (TTM)
-35.987
Free cash flow yield (TTM)
-2.78%
Free cash flow per share (TTM)
-0.231
Growth
Revenue change (TTM)
-41.48%
Earnings per share change (TTM)
-486.59%
3-year revenue growth (CAGR)
-3.76%
3-year earnings per share growth (CAGR)
43.46%
Bulls say / Bears say
Thyssenkrupp nucera successfully completed the acquisition of key technology assets from Green Hydrogen Systems, including intellectual property and a full-scale prototype test facility in Denmark, strengthening its technological leadership in electrolysis solutions. (Reuters)
Shares of NCH2 jumped 8.8% in early Frankfurt trade after the company signed a FEED study for a 600 MW green hydrogen project in Europe, underscoring strong investor confidence in its project pipeline. (Reuters)
Thyssenkrupp nucera said it will conduct a FEED study for a 260 MW green hydrogen project in India, expanding its global footprint and strengthening partnerships in emerging markets. (Reuters)
Thyssenkrupp nucera abandoned plans to establish in-house mass production of SOEC stacks, leading to a one-off impairment of approximately €30 million and widening its full-year EBIT loss forecast to €75 million–€105 million, increasing execution risk. (Reuters)
Q3 revenue fell as green hydrogen sales dropped, signaling demand volatility in its core segment and putting pressure on top-line growth. (Reuters)
The company reported an unexpected net loss of €2 million in its third quarter, missing analyst expectations and reflecting project postponements in a weak hydrogen market. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2026.
Upcoming events
No upcoming events
Funds containing NCH2
AllEURGBP
Fund name | Fund size | €NCH2 weighting |
|---|---|---|
Xtrackers MSCI Europe Small Cap€DX2J | €3.2B | 0.02% |
Xtrackers MSCI Europe Small Cap£XXSC | £2.8B | 0.02% |
SPDR MSCI All Country World IM€SPYI | €7.5B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.